TERPS Trial for de Novo Oligometastic Prostate Cancer

This study is testing whether treating all visible tumor spots (called oligometastases) with targeted radiation or ablation — in addition to standard hormone therapy — can improve outcomes for men with newly diagnosed prostate cancer that has spread to a small number of sites. **You may be eligible if...** - You have newly diagnosed prostate cancer that has spread to 1–3 bone or soft tissue sites (with at least one in bone), identified within the past 6 months - You have no symptoms from the metastases - All tumor sites are visible on imaging - You can receive hormone therapy (androgen deprivation therapy) **You may NOT be eligible if...** - You have more than 3 metastatic sites (or more than 5 on advanced imaging) - Your cancer has spread to certain areas that cannot be safely treated with radiation - You have had prior treatment for prostate cancer metastases Talk to your doctor to see if this trial is right for you.